Abstract
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Respiratory Journal |
Vol/bind | 4 |
Udgave nummer | 4 |
Sider (fra-til) | 208-14 |
Antal sider | 6 |
ISSN | 1752-6981 |
DOI | |
Status | Udgivet - 2010 |
Bibliografisk note
© 2009 Blackwell Publishing Ltd.Adgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
I: Clinical Respiratory Journal, Bind 4, Nr. 4, 2010, s. 208-14.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Management and survival of patients admitted with an exacerbation of COPD: comparison of two Danish patient cohorts
AU - Eriksen, Nanna
AU - Vestbo, Jørgen
N1 - © 2009 Blackwell Publishing Ltd.
PY - 2010
Y1 - 2010
N2 - INTRODUCTION: The aim of this study was to describe the management and prognosis related to a hospital admission for acute exacerbation of chronic obstructive pulmonary disease and to compare results to an earlier study. OBJECTIVES AND METHODS: This is a retrospective study of 300 consecutively discharged patients admitted in 2006-2007 with an exacerbation of chronic obstructive pulmonary disease from three respiratory departments. Data were collected from patient charts and compared with a replicate study done in 2001. RESULTS: The mean age was 72.1years; 61.7% were women. Mean forced expiratory volume in 1s was 37.6% of predicted. On admission, 11.3% were treated with non-invasive ventilation, and 84.3% were given systemic corticosteroids. In-hospital mortality was 4.7%. At discharge, treatment with inhaled corticosteroids or at least one long-acting bronchodilator was given to 86.7% and 89% of patients, respectively, which was significantly higher than for similarly sampled patients in 2001. Mortality in 30days and 1year after discharge was 4.5% and 25.5%, respectively, compared with 5.5% and 30.3% in 2001, the 12-month mortality being significantly lower (P=0.03). Readmission rate in the 12months following discharge was 42.3%. Long-term oxygen treatment, treatment with anti-dysrhythmic drugs and lack of outpatient follow-up were independent predictors of 1-year mortality. Risk of readmission was increased with dependence in self-care activities, previous admissions and treatment with strong analgesics. CONCLUSIONS: Over a period of 6years, a significantly higher number of patients are being treated according to guidelines. Survival following discharge increased over the same period.
AB - INTRODUCTION: The aim of this study was to describe the management and prognosis related to a hospital admission for acute exacerbation of chronic obstructive pulmonary disease and to compare results to an earlier study. OBJECTIVES AND METHODS: This is a retrospective study of 300 consecutively discharged patients admitted in 2006-2007 with an exacerbation of chronic obstructive pulmonary disease from three respiratory departments. Data were collected from patient charts and compared with a replicate study done in 2001. RESULTS: The mean age was 72.1years; 61.7% were women. Mean forced expiratory volume in 1s was 37.6% of predicted. On admission, 11.3% were treated with non-invasive ventilation, and 84.3% were given systemic corticosteroids. In-hospital mortality was 4.7%. At discharge, treatment with inhaled corticosteroids or at least one long-acting bronchodilator was given to 86.7% and 89% of patients, respectively, which was significantly higher than for similarly sampled patients in 2001. Mortality in 30days and 1year after discharge was 4.5% and 25.5%, respectively, compared with 5.5% and 30.3% in 2001, the 12-month mortality being significantly lower (P=0.03). Readmission rate in the 12months following discharge was 42.3%. Long-term oxygen treatment, treatment with anti-dysrhythmic drugs and lack of outpatient follow-up were independent predictors of 1-year mortality. Risk of readmission was increased with dependence in self-care activities, previous admissions and treatment with strong analgesics. CONCLUSIONS: Over a period of 6years, a significantly higher number of patients are being treated according to guidelines. Survival following discharge increased over the same period.
U2 - 10.1111/j.1752-699X.2009.00177.x
DO - 10.1111/j.1752-699X.2009.00177.x
M3 - Journal article
SN - 1752-6981
VL - 4
SP - 208
EP - 214
JO - Clinical Respiratory Journal
JF - Clinical Respiratory Journal
IS - 4
ER -